Search

Reset Filter

662 search results for ‘*’

Tools & Techniques Cancer

Prognostic Tumor Gene Test for Ovarian Cancer

| Olivia Gaskill

A tumor gene test has been developed that may predict poor survival in patients with ovarian cancer

Disease Area Drug discovery

Rejuvenating Alzheimer’s R&D

| Maryam Mahdi

How can we encourage companies to pursue clinical research for CNS disorders?

Research Field Immunology

Weathering the Cytokine Storm

| Charlotte Barker

THC halts the immune cascade that causes acute respiratory distress syndrome in mice

Disease Area Neurological

A Brave New World of Retina Research

| Allen C. Ho, Carl D. Regillo

Cutting-edge translational retina research for patients in Philadelphia and around the world

Research Field Cancer

“Curing Cancer? That’s Cute”

| James Strachan

Cell and gene therapies are now considered mainstream therapeutic modalities – with revolutionary potential. But that hasn’t always been the case…

Tools & Techniques Clinical trials

Trials, Interrupted

| Carl D. Regillo

Chief of the Retina Service at Wills Eye Hospital discusses the impact of COVID-19 on retina research

Superior Selectivity in Proteomics - Improving Efficiency and Sensitivity of Mass Spectrometry with FAIMS

| Contributed by Thermo Fisher Scientific

Read 3 great scientific stories using FAIMS to improve top-down, TMT, and targeted PRM experiments.

Superior Selectivity in Proteomics - Improving Efficiency and Sensitivity with FAIMS

| Contributed by Thermo Fisher Scientific

The Thermo Scientific™ FAIMS Pro™ interface is a next-generation, differential ion mobility device

Research Field Genetics

Gut Feeling

| Phoebe Harkin

Twin study investigates how gut organisms influence the immune system

Research Field Diagnostics & prognostics

Pandemic Proteomics

An MS-based proteomics platform is painting a picture of variable patient responses to COVID-19

Register to The Translational Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts

Register